It is acknowledged that during the progressive phases of the disease, the prevalence of CD8+ cells in both CNS lesions and peripheral compartments may significantly contribute to neuroinflammatory degeneration in SP-MS brains. This evidence concerns the gene CD8A and myeloid sarcoma.